Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Burkitt Lymphoma 8Leukemia, Myeloid, Acute 5Myelodysplastic Syndromes 4Lymphoma 4Leukemia, Myelomonocytic, Chronic 4Anemia, Refractory, with Excess of Blasts 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Myeloproliferative Disorders 3Leukemia, Biphenotypic, Acute 3Down Syndrome 3Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Promyelocytic, Acute 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Anemia, Refractory 2Optic Nerve Glioma 1Neutropenia 1Neoplasm Metastasis 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Eosinophilic, Acute 1Dendritic Cell Sarcoma, Interdigitating 1Congenital Abnormalities 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Cytarabine 13Daunorubicin 11Etoposide 7Filgrastim 5Peripheral Blood Stem Cell Transplantation 4Gemtuzumab 4valspodar 3Observation 3Mitoxantrone 3Busulfan 3sargramostim 2fludarabine phosphate 2aldesleukin 2Tretinoin 2Therapeutics 2Idarubicin 2Granulocyte Colony-Stimulating Factor 2Early Intervention, Educational 2Cyclophosphamide 2zosuquidar trihydrochloride 1midostaurin 1merphos 1laromustine 1etoposide phosphate 1dexamethasone acetate 1Whole-Body Irradiation 1Watchful Waiting 1Thioguanine 1Tacrolimus 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Congenital Abnormalities × Thioguanine × Clear all
NCT00005823 2013-12-18

Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

National Cancer Institute (NCI)

Phase 3 Completed
2,000 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Acute, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡